Science News
from research organizations

Lowering target blood pressure would save lives and money

Study findings could lead to new hypertension treatment guidelines for high-risk patients

Date:
May 16, 2016
Source:
Columbia University Medical Center
Summary:
A study found that lowering blood pressure goals for people with cardiovascular risk factors could save tens of thousands of lives annually and reduce costs.
Share:
FULL STORY

A more intensive systolic blood pressure (SBP) goal of 120 mmHg in patients at high risk for cardiovascular disease reduced both cardiovascular events and mortality by about one quarter, compared with the current goal of 140 mmHg.
Credit: © Photographee.eu / Fotolia

Lowering blood pressure goals for adults at high risk of cardiovascular disease could save tens of thousands of lives annually and reduce costs, according to a computer simulation by researchers at Columbia University Medical Center (CUMC) and NewYork-Presbyterian. Results of the study, published today in the online edition of Hypertension and presented today at the American Society of Hypertension Annual Scientific Meeting, could prompt a revision of national hypertension treatment guidelines, which had relaxed blood pressure goals for specific high-risk patients in recent years.

The results complement recent evidence from the Systolic Blood Pressure Intervention Trial (SPRINT), which found that having a more intensive systolic blood pressure (SBP) goal of 120 mmHg in patients at high risk for cardiovascular disease reduced both cardiovascular events and mortality by about one quarter, compared with the current goal of 140 mmHg.

In 2014, the 8th Joint National Committee (JNC8) on Detection, Evaluation, and Treatment of High Blood Pressure--appointed by the National Heart, Lung, and Blood Institute -- issued new guidelines recommending that physicians aim for an SBP of 140 mmHg in adults with diabetes and/or chronic kidney disease and 150 mmHg in healthy adults over age 60. The new guidelines represented a major departure from previous JNC7 guidelines recommending SBPs of 130 mmHg and 140, mmHg for these groups, respectively, and were not endorsed by either the American Heart Association or the American College of Cardiology. Under the 2014 guidelines, over 5 million fewer individuals annually would receive drug treatment to lower their blood pressure, compared with the prior 2003 guidelines.

The CUMC team conducted a computer simulation to determine the value of adding the lower, life-saving SBP goal identified in SPRINT to the JNC7 and JNC8 guidelines for high-risk patients between the ages of 35 and 74 years. (High risk was defined as existing cardiovascular disease, chronic kidney disease, or a 10-year cardiovascular disease risk greater than 15 percent in patients older than 50 years and with a pre-treatment SBP greater than 130 mmHg.) The researchers performed the simulation on data from a national population of adults and added data on the quality-of-life impact of side effects as well as drug and blood pressure monitoring costs.

The study found that lowering treatment goals for this population in the JNC8 guidelines would prevent up to 43,000 additional deaths from cardiovascular disease each year. Adding more intensive goals to the JNC7 guidelines would prevent an additional 35,000 deaths.

The study also revealed that adding the lower SBP goals to the JNC7 and JNC8 guidelines would decrease overall treatment costs for men and would be cost-effective (representing a good value) compared with standard treatment in women.

"Hypertension treatment is cheap and effective, and fear of side effects should not dissuade physicians from treating to lower goals in high-risk individuals under 75 years of age," said Nathalie Moise, MD, MS, lead author, assistant professor of medicine at CUMC and faculty member of the Center for Behavioral Cardiovascular Health.

Any future savings would be sensitive to higher drug costs, added Dr. Moise. "Containing drug costs will be integral to affordable implementation of intensive blood pressure goals in this high-risk group."

"Our simulation shows that we have everything to gain by taking a more aggressive approach to lowering systolic blood pressure in patients with certain cardiovascular disease risk factors," concluded Dr. Andrew Moran, MD, MPH, the Herbert Irving Assistant Professor of Medicine at CUMC and physician at NewYork-Presbyterian/Columbia.

The study is titled, "Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years: The CVD Policy Model." The other contributors are: Chen Huang (Chinese Academy of Medical Sciences, Beijing, China), Anthony Rodgers (George Institute for Global Health, Sydney, New South Wales, Australia), Ciarin N. Kohli-Lynch (CUMC and University of Glasgow, Glasgow, United Kingdom), Keane Y. Tzong (CUMC), Pamela G. Coxson (University of California at San Francisco, San Francisco, CA), Kirsten Bibbins-Domingo (University of California at San Francisco), and Lee Goldman (CUMC).

The study was funded by grants from the Health Resources and Services Administration (T32HP10260), National Heart, Lung, and Blood Institute (R01 HL10747501), and the American Heart Association Founder's Affiliate (10CRP4140089).


Story Source:

Materials provided by Columbia University Medical Center. Note: Content may be edited for style and length.


Journal Reference:

  1. Nathalie Moise, Chen Huang, Anthony Rodgers, Ciaran N. Kohli-Lynch, Keane Y. Tzong, Pamela G. Coxson, Kirsten Bibbins-Domingo, Lee Goldman, Andrew E. Moran. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35–74 Years. Hypertension, 2016; HYPERTENSIONAHA.115.06814 DOI: 10.1161/HYPERTENSIONAHA.115.06814

Cite This Page:

Columbia University Medical Center. "Lowering target blood pressure would save lives and money: Study findings could lead to new hypertension treatment guidelines for high-risk patients." ScienceDaily. ScienceDaily, 16 May 2016. <www.sciencedaily.com/releases/2016/05/160516095138.htm>.
Columbia University Medical Center. (2016, May 16). Lowering target blood pressure would save lives and money: Study findings could lead to new hypertension treatment guidelines for high-risk patients. ScienceDaily. Retrieved May 24, 2017 from www.sciencedaily.com/releases/2016/05/160516095138.htm
Columbia University Medical Center. "Lowering target blood pressure would save lives and money: Study findings could lead to new hypertension treatment guidelines for high-risk patients." ScienceDaily. www.sciencedaily.com/releases/2016/05/160516095138.htm (accessed May 24, 2017).

RELATED STORIES